Alta Life Sciences is the famous VC, which was founded in 2016. The main office of represented VC is situated in the Barcelona. The company was established in Europe in Spain.
Among the various public portfolio startups of the fund, we may underline SANIFIT, Mediktor, Bionure The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Spain. We can highlight the next thriving fund investment areas, such as Wellness, Health Care. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.
This organization was formed by Guy P. Nohra.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Alta Life Sciences, startups are often financed by Ministerio de Economia y Competitividad, Healthequity, Caixa Capital Risc. The meaningful sponsors for the fund in investment in the same round are Ysios Capital, Naos, Lundbeckfonden Ventures. In the next rounds fund is usually obtained by Horizon 2020.
Related Funds
Funds with similar focus
Fund Name | Location |
3VC | Austria, Vienna |
a>m ventures | Memphis, Tennessee, United States |
Banca Sella Group | Biella, Italy, Piemonte |
Beam Capital | China, Hong Kong, Hong Kong Island |
Bushiroad Music | Japan, Tokyo |
Hainei Ziben | China, Guangdong Province, Huizhou |
Lanying Information Technology | China, Guangdong, Shenzhen |
Mercia Asset Management | England, Stratford-on-Avon, United Kingdom |
NTT Plala | Japan, Toshima |
OperatorVC | Ghaziabad, India, Uttar Pradesh |
Relia | Japan, Kanagawa Prefecture, Kawasaki |
StepStone Real Estate | - |
Stripe | California, San Francisco, United States |
Table Mountain Ventures | New York, New York, United States |
The Artemis Fund | Houston, Texas, United States |
The Contrarian Group | California, Newport Beach, United States |
The Riva Group | Dubai, United Arab Emirates |
Vitalbridge Capital | China, Shanghai |
Zhuoli lengqi | China, Foshan, Guangdong |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
DeepUll | $15M | 20 Oct 2022 | Barcelona, Catalonia, Spain | ||
INBRAIN Neuroelectronics | $19M | 26 Mar 2021 | Barcelona, Catalonia, Spain | ||
DeepUll | $4M | 07 Jul 2020 | Spain, Catalonia | ||
Ona Therapeutics | $35M | 16 Jun 2020 | Spain, Catalonia | ||
INBRAIN Neuroelectronics | $1M | 11 Jun 2020 | Spain, Catalonia | ||
Accure Therapeutics | $8M | 26 May 2020 | Barcelona, Catalonia, Spain | ||
Mediktor | $3M | 01 Oct 2018 | Barcelona, Catalonia, Spain | ||
Bionure | $4M | 17 May 2018 | - | ||
Peptomyc | $4M | 11 Sep 2017 | Barcelona, Catalonia, Spain |
– INBRAIN Neuroelectronics S.L. announced $16.8m in Series A funding for its disruptive system for treating epilepsy and Parkinson’s disease.
– The investment was co-led by Asabys Partners and Alta Life Sciences and joined by Vsquared Ventures and TruVenturo GmbH.
– The funding will be used to advance INBRAIN’s first-in-human clinical program, aiming to establish the safety of graphene as the new standard of care for neurotechnology devices.
– INBRAIN’s technology harnesses the power of graphene, a two-dimensional material first isolated in 2004 made of a lattice of carbon atoms only one atom thick.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
DeepUll | $15M | 20 Oct 2022 | Barcelona, Catalonia, Spain | ||
INBRAIN Neuroelectronics | $19M | 26 Mar 2021 | Barcelona, Catalonia, Spain | ||
DeepUll | $4M | 07 Jul 2020 | Spain, Catalonia | ||
Ona Therapeutics | $35M | 16 Jun 2020 | Spain, Catalonia | ||
INBRAIN Neuroelectronics | $1M | 11 Jun 2020 | Spain, Catalonia | ||
Accure Therapeutics | $8M | 26 May 2020 | Barcelona, Catalonia, Spain | ||
Mediktor | $3M | 01 Oct 2018 | Barcelona, Catalonia, Spain | ||
Bionure | $4M | 17 May 2018 | - | ||
Peptomyc | $4M | 11 Sep 2017 | Barcelona, Catalonia, Spain |